Safety and 30-day outcomes of tracheostomy for COVID-19 : a prospective observational cohort study

Copyright © 2020 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved..

BACKGROUND: The role of tracheostomy in coronavirus disease 2019 (COVID-19) is unclear, with several consensus guidelines advising against this practice. We developed both a dedicated airway team and coordinated education programme to facilitate ward management of tracheostomised COVID-19 patients. Here, we report outcomes in the first 100 COVID-19 patients who underwent tracheostomy at our institution.

METHODS: This was a prospective observational cohort study of patients confirmed to have COVID-19 who required mechanical ventilation at Queen Elizabeth Hospital, Birmingham, UK. The primary outcome measure was 30-day survival, accounting for severe organ dysfunction (Acute Physiology and Chronic Health [APACHE]-II score>17). Secondary outcomes included duration of ventilation, ICU stay, and healthcare workers directly involved in tracheostomy care acquiring COVID-19.

RESULTS: A total of 164 patients with COVID-19 were admitted to the ICU between March 9, 2020 and April 21, 2020. A total of 100 patients (mean [standard deviation] age: 55 [12] yr; 29% female) underwent tracheostomy; 64 (age: 57 [14] yr; 25% female) did not undergo tracheostomy. Despite similar APACHE-II scores, 30-day survival was higher in 85/100 (85%) patients after tracheostomy, compared with 27/64 (42%) non-tracheostomised patients {relative risk: 3.9 (95% confidence intervals [CI]: 2.3-6.4); P<0.0001}. In patients with APACHE-II scores ≥17, 68/100 (68%) tracheotomised patients survived, compared with 12/64 (19%) non-tracheotomised patients (P<0.001). Tracheostomy within 14 days of intubation was associated with shorter duration of ventilation (mean difference: 6.0 days [95% CI: 3.1-9.0]; P<0.0001) and ICU stay (mean difference: 6.7 days [95% CI: 3.7-9.6]; P<0.0001). No healthcare workers developed COVID-19.

CONCLUSION: Independent of the severity of critical illness from COVID-19, 30-day survival was higher and ICU stay shorter in patients receiving tracheostomy. Early tracheostomy appears to be safe in COVID-19.

Errataetall:

CommentIn: Br J Anaesth. 2020 Dec;125(6):867-871. - PMID 32951840

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:125

Enthalten in:

British journal of anaesthesia - 125(2020), 6 vom: 10. Dez., Seite 872-879

Sprache:

Englisch

Beteiligte Personen:

Queen Elizabeth Hospital Birmingham COVID-19 airway team [VerfasserIn]
Breik, Omar [Sonstige Person]
Nankivell, Paul [Sonstige Person]
Sharma, Neil [Sonstige Person]
Bangash, Mansoor N [Sonstige Person]
Dawson, Camilla [Sonstige Person]
Idle, Matthew [Sonstige Person]
Isherwood, Peter [Sonstige Person]
Jennings, Christopher [Sonstige Person]
Keene, Damian [Sonstige Person]
Manji, Mav [Sonstige Person]
Martin, Tim [Sonstige Person]
Moss, Rob [Sonstige Person]
Murphy, Nick [Sonstige Person]
Parekh, Dhruv [Sonstige Person]
Parmar, Sat [Sonstige Person]
Patel, Jaimin [Sonstige Person]
Pracy, Paul [Sonstige Person]
Praveen, Prav [Sonstige Person]
Richardson, Carla [Sonstige Person]
Richter, Alex [Sonstige Person]
Sachdeva, Rajneesh [Sonstige Person]
Shields, Adrian [Sonstige Person]
Siddiq, Somiah [Sonstige Person]
Smart, Simon [Sonstige Person]
Tasker, Laura [Sonstige Person]

Links:

Volltext

Themen:

COVID-19
ICU
Journal Article
Observational Study
SARS-CoV-2
Safety
Tracheostomy

Anmerkungen:

Date Completed 25.11.2020

Date Revised 10.01.2021

published: Print-Electronic

CommentIn: Br J Anaesth. 2020 Dec;125(6):867-871. - PMID 32951840

Citation Status MEDLINE

doi:

10.1016/j.bja.2020.08.023

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM315592869